Vicky Avery
Vicky Avery
Verified email at griffith.edu.au
Title
Cited by
Cited by
Year
Chemical genetics of Plasmodium falciparum
WA Guiguemde, AA Shelat, D Bouck, S Duffy, GJ Crowther, PH Davis, ...
Nature 465 (7296), 311-315, 2010
5572010
A novel multiple-stage antimalarial agent that inhibits protein synthesis
B Baragaña, I Hallyburton, MCS Lee, NR Norcross, R Grimaldi, TD Otto, ...
Nature 522 (7556), 315-320, 2015
2712015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
MA Phillips, J Lotharius, K Marsh, J White, A Dayan, KL White, ...
Science translational medicine 7 (296), 296ra111-296ra111, 2015
2162015
Advanced cell culture techniques for cancer drug discovery
CJ Lovitt, TB Shelper, VM Avery
Biology 3 (2), 345-367, 2014
2122014
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond
WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ...
PLoS pathogens 12 (7), e1005763, 2016
1902016
Quinolone-3-diarylethers: a new class of antimalarial drug
A Nilsen, AN LaCrue, KL White, IP Forquer, RM Cross, J Marfurt, ...
Science translational medicine 5 (177), 177ra37-177ra37, 2013
1882013
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
MB Jiménez-Díaz, D Ebert, Y Salinas, A Pradhan, AM Lehane, ...
Proceedings of the National Academy of Sciences 111 (50), E5455-E5462, 2014
1812014
Flinderoles A−C: Antimalarial Bis-indole Alkaloids from Flindersia Species
LS Fernandez, MS Buchanan, AR Carroll, YJ Feng, RJ Quinn, VM Avery
Organic letters 11 (2), 329-332, 2009
1752009
Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
N Kato, E Comer, T Sakata-Kato, A Sharma, M Sharma, M Maetani, ...
Nature 538 (7625), 344-349, 2016
1642016
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
CJ Lovitt, TB Shelper, VM Avery
BMC cancer 18 (1), 1-11, 2018
1482018
Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening
S Duffy, VM Avery
The American journal of tropical medicine and hygiene 86 (1), 84-92, 2012
1342012
Identification of inhibitors of Plasmodium falciparum gametocyte development
S Duffy, VM Avery
Malaria journal 12 (1), 1-15, 2013
1292013
3, 5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential
Y Younis, F Douelle, TS Feng, DG Cabrera, CL Manach, AT Nchinda, ...
Journal of medicinal chemistry 55 (7), 3479-3487, 2012
1282012
Leishmaniasis drug discovery: recent progress and challenges in assay development
B Zulfiqar, TB Shelper, VM Avery
Drug discovery today 22 (10), 1516-1531, 2017
1252017
Natural Products, Stylissadines A and B, Specific Antagonists of the P2X7 Receptor, an Important Inflammatory Target1
MS Buchanan, AR Carroll, R Addepalli, VM Avery, JNA Hooper, RJ Quinn
The Journal of organic chemistry 72 (7), 2309-2317, 2007
1192007
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
AB Vaidya, JM Morrisey, Z Zhang, S Das, TM Daly, TD Otto, NJ Spillman, ...
Nature communications 5 (1), 1-10, 2014
1062014
Development of an Alamar Blue™ viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
ML Sykes, VM Avery
The American journal of tropical medicine and hygiene 81 (4), 665-674, 2009
1022009
Identification of MMV malaria box inhibitors of Plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay
L Lucantoni, S Duffy, SH Adjalley, DA Fidock, VM Avery
Antimicrobial agents and chemotherapy 57 (12), 6050-6062, 2013
1012013
Antimalarial Activity of Azafluorenone Alkaloids from the Australian Tree Mitrephora diversifolia
D Mueller, RA Davis, S Duffy, VM Avery, D Camp, RJ Quinn
Journal of natural products 72 (8), 1538-1540, 2009
892009
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign
ML Sykes, JB Baell, M Kaiser, E Chatelain, SR Moawad, D Ganame, ...
PLoS Negl Trop Dis 6 (11), e1896, 2012
852012
The system can't perform the operation now. Try again later.
Articles 1–20